Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Publications

Raman, Vignesh, Chi-Fu Jeffrey Yang, John Z. Deng, and Thomas A. D’Amico. “Surgical treatment for early stage non-small cell lung cancer.” J Thorac Dis 10, no. Suppl 7 (April 2018): S898–904. https://doi.org/10.21037/jtd.2018.01.172.

Full Text

Yang, Chi-Fu Jeffrey, Frances McSherry, Nicholas R. Mayne, Xiaofei Wang, Mark F. Berry, Betty Tong, David H. Harpole, et al. “Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.” Ann Thorac Surg 105, no. 3 (March 2018): 924–29. https://doi.org/10.1016/j.athoracsur.2017.09.030.

Full Text

Gulack, Brian C., Morgan L. Cox, Chi-Fu Jeffrey Yang, Paul J. Speicher, H Volkan Kara, Thomas A. D’Amico, Mark F. Berry, and Matthew G. Hartwig. “Survival after radiation for stage I and II non-small cell lung cancer with positive margins.” J Surg Res 223 (March 2018): 94–101. https://doi.org/10.1016/j.jss.2017.10.025.

Full Text

Zeng, Yuan, Wenhua Liang, Jun Liu, Jiaxi He, Calvin S. H. Ng, Chia-Chuan Liu, René Horsleben Petersen, et al. “Esophageal cancer in elderly patients: a population-based study.” J Thorac Dis 10, no. 1 (January 2018): 448–57. https://doi.org/10.21037/jtd.2018.01.89.

Full Text

Yang, Chi-Fu Jeffrey, Lin Gu, Shivani A. Shah, Babatunde A. Yerokun, Thomas A. D’Amico, Matthew G. Hartwig, and Mark F. Berry. “Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.” Lung Cancer 115 (January 2018): 75–83. https://doi.org/10.1016/j.lungcan.2017.11.021.

Full Text

Cheng, Xinghua, Mark W. Onaitis, Thomas A. D’amico, and Haiquan Chen. “Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery.” Ann Surg 267, no. 1 (January 2018): 37–38. https://doi.org/10.1097/SLA.0000000000002405.

Full Text

Yi, John S., Neal Ready, Patrick Healy, Chelsae Dumbauld, Robyn Osborne, Mark Berry, Debra Shoemaker, et al. “Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.” Clin Cancer Res 23, no. 24 (December 15, 2017): 7474–82. https://doi.org/10.1158/1078-0432.CCR-17-2005.

Full Text

Yang, Chi-Fu Jeffrey, Hanghang Wang, Arvind Kumar, Xiaofei Wang, Matthew G. Hartwig, Thomas A. D’Amico, and Mark F. Berry. “Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma.” Chest 152, no. 6 (December 2017): 1239–50. https://doi.org/10.1016/j.chest.2017.07.032.

Full Text

Kapadia, Nirav S., Luca F. Valle, Julie A. George, Reshma Jagsi, Thomas A. D’Amico, Elisabeth U. Dexter, Fawn D. Vigneau, and Feng Ming Kong. “Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer.” Ann Thorac Surg 104, no. 6 (December 2017): 1881–88. https://doi.org/10.1016/j.athoracsur.2017.06.065.

Full Text

Pages